These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 30827180)

  • 1. Non-invasive massive growing prostheses reduce infection in paediatric cancer patients.
    Coathup MJ; Ahmad S; Maempel JF; Briggs TW; Aston WJ; Skinner JA; Blunn GW
    J Orthop Surg (Hong Kong); 2019; 27(1):2309499019833403. PubMed ID: 30827180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What is the morbidity of a non-invasive growing prosthesis?
    Gilg MM; Gaston CL; Parry MC; Jeys L; Abudu A; Tillman RM; Carter SR; Grimer RJ
    Bone Joint J; 2016 Dec; 98-B(12):1697-1703. PubMed ID: 27909134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of a Modular Intercalary Endoprosthesis as Treatment for Segmental Defects of the Femur, Tibia, and Humerus.
    Benevenia J; Kirchner R; Patterson F; Beebe K; Wirtz DC; Rivero S; Palma M; Friedrich MJ
    Clin Orthop Relat Res; 2016 Feb; 474(2):539-48. PubMed ID: 26475032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total Femur Replacement After Tumor Resection: Limb Salvage Usually Achieved But Complications and Failures are Common.
    Sevelda F; Schuh R; Hofstaetter JG; Schinhan M; Windhager R; Funovics PT
    Clin Orthop Relat Res; 2015 Jun; 473(6):2079-87. PubMed ID: 25832007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of minimally invasive and non-invasive systems in lengthening total femoral prostheses.
    Medellin MR; Fujiwara T; Clark R; Jeys LM
    Bone Joint J; 2018 Dec; 100-B(12):1640-1646. PubMed ID: 30499323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of principles inspiring design of three-dimensional-printed custom-made prostheses in two referral centres.
    Angelini A; Kotrych D; Trovarelli G; Szafrański A; Bohatyrewicz A; Ruggieri P
    Int Orthop; 2020 May; 44(5):829-837. PubMed ID: 32170471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of current production tumor endoprostheses: complications, functional results, and a comparative statistical analysis.
    Pala E; Henderson ER; Calabrò T; Angelini A; Abati CN; Trovarelli G; Ruggieri P
    J Surg Oncol; 2013 Nov; 108(6):403-8. PubMed ID: 24006247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival of cemented distal femoral endoprostheses with a hydroxyapatite-coated collar: a histological study and a radiographic follow-up.
    Coathup MJ; Batta V; Pollock RC; Aston WJ; Cannon SR; Skinner JA; Briggs TW; Unwin PS; Blunn GW
    J Bone Joint Surg Am; 2013 Sep; 95(17):1569-75. PubMed ID: 24005197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early results of a non-invasive extendible prosthesis for limb-salvage surgery in children with bone tumours.
    Hwang N; Grimer RJ; Carter SR; Tillman RM; Abudu A; Jeys LM
    J Bone Joint Surg Br; 2012 Feb; 94(2):265-9. PubMed ID: 22323698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dual-center review of compressive osseointegration for fixation of massive endoprosthetics: 2- to 9-year followup.
    Calvert GT; Cummings JE; Bowles AJ; Jones KB; Wurtz LD; Randall RL
    Clin Orthop Relat Res; 2014 Mar; 472(3):822-9. PubMed ID: 23467985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infective complications in tumour endoprostheses implanted after pathological fracture of the limbs.
    Piccioli A; Donati F; Giacomo GD; Ziranu A; Careri S; Spinelli MS; Giannini S; Giannicola G; Perisano C; Maccauro G
    Injury; 2016 Oct; 47 Suppl 4():S22-S28. PubMed ID: 27568843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late complications and survival of endoprosthetic reconstruction after resection of bone tumors.
    Shehadeh A; Noveau J; Malawer M; Henshaw R
    Clin Orthop Relat Res; 2010 Nov; 468(11):2885-95. PubMed ID: 20625951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physeal-preserving endoprosthetic replacement with short segment fixation in children with bone sarcomas.
    Tsuda Y; Fujiwara T; Sree D; Stevenson JD; Evans S; Abudu A
    Bone Joint J; 2019 Sep; 101-B(9):1144-1150. PubMed ID: 31474137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stanmore custom-made extendible distal femoral replacements. Clinical experience in children with primary malignant bone tumours.
    Schindler OS; Cannon SR; Briggs TW; Blunn GW
    J Bone Joint Surg Br; 1997 Nov; 79(6):927-37. PubMed ID: 9393906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The medium-term results of the Stanmore non-invasive extendible endoprosthesis in the treatment of paediatric bone tumours.
    Picardo NE; Blunn GW; Shekkeris AS; Meswania J; Aston WJ; Pollock RC; Skinner JA; Cannon SR; Briggs TW
    J Bone Joint Surg Br; 2012 Mar; 94(3):425-30. PubMed ID: 22371554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Compressive Osseointegration Endoprostheses for Massive Bone Loss From Tumor and Failed Arthroplasty: A Viable Option in the Upper Extremity.
    Goulding KA; Schwartz A; Hattrup SJ; Randall RL; Lee D; Rispoli DM; Lerman DM; Beauchamp C
    Clin Orthop Relat Res; 2017 Jun; 475(6):1702-1711. PubMed ID: 28194713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LUMiC
    Bus MP; Szafranski A; Sellevold S; Goryn T; Jutte PC; Bramer JA; Fiocco M; Streitbürger A; Kotrych D; van de Sande MA; Dijkstra PD
    Clin Orthop Relat Res; 2017 Mar; 475(3):686-695. PubMed ID: 27020434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aseptic loosening is uncommon with uncemented proximal tibia tumor prostheses.
    Flint MN; Griffin AM; Bell RS; Ferguson PC; Wunder JS
    Clin Orthop Relat Res; 2006 Sep; 450():52-9. PubMed ID: 16906064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extendible Prostheses for Children After Resection of Primary Malignant Bone Tumor: Twenty-seven Years of Experience.
    Schinhan M; Tiefenboeck T; Funovics P; Sevelda F; Kotz R; Windhager R
    J Bone Joint Surg Am; 2015 Oct; 97(19):1585-91. PubMed ID: 26446966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silver-coated (Agluna®) tumour prostheses can be a protective factor against infection in high risk failure patients.
    Parry MC; Laitinen MK; Albergo JI; Gaston CL; Stevenson JD; Grimer RJ; Jeys LM
    Eur J Surg Oncol; 2019 Apr; 45(4):704-710. PubMed ID: 30591310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.